n-vinyl-2-pyrrolidinone has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cradock, JC; Davignon, JP; Rahman, A | 1 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Leukemia L 1210
| Article | Year |
|---|---|
Dissolution and absorption of the antineoplastic agent ellipticine.
Topics: Administration, Oral; Alkaloids; Animals; Ellipticines; Excipients; Injections, Intraperitoneal; Intestinal Absorption; Leukemia L1210; Male; Mice; Povidone; Solubility; Solutions; Suspensions; Tablets; Tissue Distribution | 1978 |